Cetuximab and vemurafenib plus FOLFIRIĀ (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial
Titel:
Cetuximab and vemurafenib plus FOLFIRIĀ (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial
Auteur:
Wang, Zhan Qin, Bao-Dong Ye, Chen-Yang Wang, Miao-Miao Yuan, Ling-Yan Dai, Wei-Ping Sun, Li Liu, Ke Qin, Wen-Xing Jiao, Xiao-Dong Li, Xing-Nan Zang, Yuan-Sheng